Kairos Pharma, Ltd. KAPA
0.49 USD -0.02 (-3.03%)
Nov 4, 2026, 3:58 PM EST
0.4897 Day range 0.5298
0.418 52-week range 7.28
- YTD
- -90.15%
- 1 year
- -91.93%
Analyst view
Price target (mean) 9.00
Ratings (0m) 1 1 buy · 0 hold · 0 sell
- Strong buy0
- Buy1
- Hold0
- Sell0
- Strong sell0
Recommendation trend
- This month 1
- 1 month ago 1
Earnings and revenue estimates
Consensus for the coming quarters and fiscal years
| Period | EPS estimate | Low – high | Year ago | EPS growth | Revenue estimate | Revenue growth | Analysts |
|---|---|---|---|---|---|---|---|
| Current quarter | -0.02 | -0.02 – -0.02 | 0.00 | 0.0% | 0 | 0.0% | 1 |
| Current year | -0.10 | -0.10 – -0.10 | 0.00 | 0.0% | 0 | 0.0% | 1 |
| Next year | -0.23 | -0.23 – -0.23 | -0.10 | -130.0% | 0 | 0.0% | 1 |
Upgrades and downgrades
The latest rating changes
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Nov 14, 2024 | D. Boral Capital | Maintained | Buy | Buy |
| Oct 14, 2024 | EF Hutton | Initiated | — | Buy |